Imbalance between matrix metalloproteinase 9 and tissue inhibitor of metalloproteinases 1 expression by tumor cells implicated in liver metastasis from colorectal carcinoma

Kurume Medical Journal

Volumn 48, Issue 3, 2001, Pages 211-218

  Ogata, Yutaka ^a   Miura, Kazuhide ^a   Ohkita, Akira ^a   Nagase, Hideaki ^b   Shirouzu, Kazuo ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Colorectal cancer; In situ hybridization; Liver metastasis; Matrix metalloproteinase 9 (MMP 9); Tissue inhibitor of metalloproteinases 1 (TIMP 1)

Indexed keywords

GELATINASE B; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; AGED; ANIMAL; ARTICLE; COLORECTAL TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LIVER TUMOR; MALE; METABOLISM; METASTASIS; MIDDLE AGED; MOUSE; NUDE MOUSE;

ADULT; AGED; ANIMALS; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, NUDE; MIDDLE AGED; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 0035238445     PISSN: 00235679     EISSN: None     Source Type: Journal    
DOI: 10.2739/kurumemedj.48.211     Document Type: Article

References (21)

1. Poste G, and Fidler IJ. The pathogenesis of cancer metastasis. Nature 1980; 283:139-146.
2. Monteagudo C, Merino MJ, San-Juan J, Liotta LA, and Stetler-Stevenson WG. Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue. Am J Pathol 1990; 136:585-592.
3. Stearns ME, and Wang M. Type IV collagenase (Mr 72,000) expression in human prostate: benign and malignant tissue. Cancer Res 1993; 53:878-883.
4. Pyke C, Ralfkiaer E, Tryggvason K, and Dano K. Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer. Am J Pathol 1993; 142:359-365.
5. Sopata I, and Dancewicz AM. Presence of a gelatin-specific proteinase and its latent form in human leukocytes. Biochem Biophys Acta 1974; 370:510-523.
6. Morodomi T, Ogata Y, Sasaguri Y, Morimatu M, and Nagase H. Purification and characterization of matrix metalloproteinase-9 from U937 monocytic leukemia and HT1080 fibrosarcoma cells. Biochem J 1992; 285:603-611.
7. Murphy G, Cockett MI, Ward RV, and Docherty AJP. Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan: a quantitative comparison of the activities of 95kDa and 72kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP). Biochem J 1991; 277:277-279.
8. Woessner JFJ. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991; 5:2145-2154.
9. Stetler-Stevenson WG, Krutzsch HC, and Liotta LA. Tissue inhibitor of metalloproteinase (TIMP-2): a new member of the metalloproteinase inhibitor family. J Biol Chem 1989; 264:17374-17378.
10. Apte SS, Mattei MG, and Olsen BR. Cloning of the cDNA encoding human tissue inhibitor of metalloproteinase-3 (TIMP-3) and mapping of the TIMP-3 gene to chromosome 22. Genomics 1994; 19:86-90.
11. Greene J, Wang M, Liu YE, Raymond LA, Rosen C et al. Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J Biol Chem 1996; 271:30375-30380.
12. Ogata Y, Itoh Y, and Nagase H. Steps involved in activation of the pro-matrix metalloproteinase 9 (progelatinase B)-tissue inhibitor of metalloproteinases-1 complex by 4-aminophenylmercuric acetate and proteinases. J Biol Chem 1995; 270:18506-18511.
13. Ogata Y, Hara Y, Akagi Y, Ohkita A, Morodomi T et al. Metastatic model of human colon cancer constructed using orthotopic implantation in nude mice. Kurume Med J 1998; 45:121-125.
14. Morikawa K, Shirley M, Nakajima M, Pathak S, Jessup JM et al. Influence of organ environment of the growth, selection and metastasis of human colon carcinoma cells in nude mice. Cancer Res 1988; 48:6863-6871.
15. Karbel RS. Growth dominance of the metastatic cancer cell: cellular and molecular aspects. Adv Cancer Res 1990; 55:87-131.
16. Stetler-Stevenson WG. Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev 1990; 9:289-303.
17. Liotta LA, and Stetler-Stevenson WG. Metalloproteinases and cancer invasion. Semin Cancer Biol 1990; 1:99-106.
18. Grigioni WF, D'Errico A, Fortunato C, Fiorentino M, Mancini AM et al. Prognosis of gastric carcinoma revealed by interactions between tumor cells and basement membrane. Mod Pathol 1994; 7:220-225.
19. Hoyhta M, Fridman R, Komarek D, Porter-Jordan K, Stetler-Stevenson WG et al. Immunohistochemical localization of matrix metalloproteinase 2 and its specific inhibitor TIMP-2 in neoplastic tissues with monoclonal antibodies. Int J Cancer 1994; 56:500-505.
20. Poulsom R, Hanby AM, Pignatelli M, Jeffery RE, Longcroft JM et al. Expression of gelatinase A and TIMP-2 mRNAs in desmoplastic fibroblasts in both mammary carcinomas and basal cell carcinomas of the skin. J Clin Pathol 1993; 46:429-436.
21. Murashige M, Miyahara M, Shiraishi N, Saito T, Kohno K et al. Enhanced expression of tissue inhibitor of metalloproteinases in human colorectal tumors. Jpn J Clin Oncol 1996; 26:303-309.